Journal article icon

Journal article

Hydroxychloroquine retinopathy.

Abstract:

Hydroxychloroquine (HCQ; Plaquenil) is used increasingly in the management of a variety of autoimmune disorders, with well established roles in dermatology and rheumatology and emerging roles in oncology. Hydroxychloroquine has demonstrated a survival benefit in patients with systemic lupus erythematosus; some clinicians advocate its use in all such patients. However Hydroxychloroquine and chloroquine (CQ) have been associated with irreversible visual loss due to retinal toxicity. Hydroxychlo...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted manuscript

Actions


Access Document


Files:
Publisher copy:
10.1038/eye.2016.298

Authors


More by this author
Department:
Merton College
More by this author
Department:
Oxford, MSD, Clinical Neurosciences
More by this author
Department:
Oxford, MSD, NDORMS
More by this author
Department:
Oxford, MSD, Clinical Neurosciences
Publisher:
Nature Publishing Group Publisher's website
Journal:
Eye Journal website
Volume:
31
Issue:
6
Pages:
828-845
Publication date:
2017-03-05
Acceptance date:
2016-08-24
DOI:
EISSN:
1476-5454
ISSN:
0950-222X
Pubs id:
pubs:685370
URN:
uri:4ffa9df5-3f98-48d3-9dc4-d895deb29d7f
UUID:
uuid:4ffa9df5-3f98-48d3-9dc4-d895deb29d7f
Local pid:
pubs:685370
Language:
English
Keywords:

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP